Trials / Completed
CompletedNCT00303979
IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34,810 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to characterize current management of patients with either heart failure or prior myocardial infarction and left ventricular dysfunction and to assess the effect of education, specific clinical guidelines, reminder systems, comprehensive disease state management tools, benchmarked quality reports, and academic detailing on the use of evidence-based heart failure therapies in cardiology practices. This study is a quality improvement initiative that is being conducted through review of patient records.
Detailed description
IMPROVE HF, the largest US outpatient HF patient registry, has substantially contributed to our knowledge of how systolic HF and post MI left ventricular systolic dysfunction (LVSD) patients are treated in the outpatient setting. The findings of IMPROVE HF clearly support this guideline and may help to establish a model framework for future performance improvement programs for outpatient cardiology practices.
Conditions
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2009-08-01
- Completion
- 2009-08-01
- First posted
- 2006-03-17
- Last updated
- 2019-01-31
- Results posted
- 2012-12-27
Locations
144 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00303979. Inclusion in this directory is not an endorsement.